Review Article Open Access October 03, 2023

Pharmaceutical Drug Serialization: A Comprehensive Review

1
Herndon, Virginia, United States
Page(s): 26-33
Received
August 18, 2023
Revised
September 19, 2023
Accepted
September 26, 2023
Published
October 03, 2023
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2023. Published by Scientific Publications
Article metrics
Views
2029
Downloads
241

Cite This Article

APA Style
Gupta, A. (2023). Pharmaceutical Drug Serialization: A Comprehensive Review. Current Research in Public Health, 2(1), 26-33. https://doi.org/10.31586/ujpp.2023.786
ACS Style
Gupta, A. Pharmaceutical Drug Serialization: A Comprehensive Review. Current Research in Public Health 2023 2(1), 26-33. https://doi.org/10.31586/ujpp.2023.786
Chicago/Turabian Style
Gupta, Aarav. 2023. "Pharmaceutical Drug Serialization: A Comprehensive Review". Current Research in Public Health 2, no. 1: 26-33. https://doi.org/10.31586/ujpp.2023.786
AMA Style
Gupta A. Pharmaceutical Drug Serialization: A Comprehensive Review. Current Research in Public Health. 2023; 2(1):26-33. https://doi.org/10.31586/ujpp.2023.786
@Article{crph786,
AUTHOR = {Gupta, Aarav},
TITLE = {Pharmaceutical Drug Serialization: A Comprehensive Review},
JOURNAL = {Current Research in Public Health},
VOLUME = {2},
YEAR = {2023},
NUMBER = {1},
PAGES = {26-33},
URL = {https://www.scipublications.com/journal/index.php/UJPP/article/view/786},
ISSN = {2831-5162},
DOI = {10.31586/ujpp.2023.786},
ABSTRACT = {A persistent problem in the pharmaceutical industry that has existed for centuries is the prevalence of counterfeit drugs, and the World Health Organization (WHO) estimates that millions of people are affected by this issue each year. In particular, 4 out of 10 drugs in poor or underdeveloped countries may be adulterated, which can lead to severe adverse events. To address this problem, many countries have implemented regulatory compliance measures such as pharmaceutical drug serialization, which requires the unique identification of every drug package manufactured. This enables tracking and tracing of individual packages throughout the supply chain and helps to prevent counterfeit drugs from entering the market. In this paper, we conduct a systematic review of the serialization process evaluation and its impact on the pharmaceutical industry. We discuss the benefits of pharmaceutical drug serialization, including its ability to improve drug security and reduce adverse events and investigations. We also examine the challenges associated with implementing serialization processes and the regulatory requirements necessary for compliance. Finally, we explore the various tracking and tracing technologies used in serialization processes and their effectiveness in preventing the distribution of counterfeit drugs. Overall, this paper highlights the importance of pharmaceutical drug serialization in ensuring the safety and efficacy of drugs in the healthcare industry, particularly in poor or underdeveloped countries where the problem of adulterated drugs is especially prevalent.},
}
%0 Journal Article
%A Gupta, Aarav
%D 2023
%J Current Research in Public Health

%@ 2831-5162
%V 2
%N 1
%P 26-33

%T Pharmaceutical Drug Serialization: A Comprehensive Review
%M doi:10.31586/ujpp.2023.786
%U https://www.scipublications.com/journal/index.php/UJPP/article/view/786
TY  - JOUR
AU  - Gupta, Aarav
TI  - Pharmaceutical Drug Serialization: A Comprehensive Review
T2  - Current Research in Public Health
PY  - 2023
VL  - 2
IS  - 1
SN  - 2831-5162
SP  - 26
EP  - 33
UR  - https://www.scipublications.com/journal/index.php/UJPP/article/view/786
AB  - A persistent problem in the pharmaceutical industry that has existed for centuries is the prevalence of counterfeit drugs, and the World Health Organization (WHO) estimates that millions of people are affected by this issue each year. In particular, 4 out of 10 drugs in poor or underdeveloped countries may be adulterated, which can lead to severe adverse events. To address this problem, many countries have implemented regulatory compliance measures such as pharmaceutical drug serialization, which requires the unique identification of every drug package manufactured. This enables tracking and tracing of individual packages throughout the supply chain and helps to prevent counterfeit drugs from entering the market. In this paper, we conduct a systematic review of the serialization process evaluation and its impact on the pharmaceutical industry. We discuss the benefits of pharmaceutical drug serialization, including its ability to improve drug security and reduce adverse events and investigations. We also examine the challenges associated with implementing serialization processes and the regulatory requirements necessary for compliance. Finally, we explore the various tracking and tracing technologies used in serialization processes and their effectiveness in preventing the distribution of counterfeit drugs. Overall, this paper highlights the importance of pharmaceutical drug serialization in ensuring the safety and efficacy of drugs in the healthcare industry, particularly in poor or underdeveloped countries where the problem of adulterated drugs is especially prevalent.
DO  - Pharmaceutical Drug Serialization: A Comprehensive Review
TI  - 10.31586/ujpp.2023.786
ER  -